PropertyValue
?:abstract
  • Coronavirus disease 2019 (COVID-19), like cancer, is a complex disease with clinical phases of progression. Initially conceptualized as a respiratory disease, COVID-19 is increasingly recognized as a multi-organ and heterogeneous illness. Disease staging is a method for measuring the progression and severity of an illness using objective clinical and molecular criteria. Integral to cancer staging is “metastasis,” defined as the spread of a disease-producing agent, including neoplastic cells and pathogens such as certain viruses, from the primary site to distinct anatomic locations. Staging provides valuable frameworks and benchmarks for clinical decision-making in patient management, improved prognostication, and evidence-based treatment selection.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1016/j.ccell.2020.10.006
?:journal
  • Cancer_Cell
?:license
  • els-covid
?:pdf_json_files
  • document_parses/pdf_json/52d72f4a9a86a30e9d9d7c2f172cc140f6a35e8e.json
?:pmcid
?:pmid
?:pmid
  • 33086031.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • COVID-19: Staging of a New Disease
?:type
?:year
  • 2020-10-10

Metadata

Anon_0  
expand all